3D Ready Organoid
| Cat No. | C-060 |
| Organism | Human |
| Tissue | Cervical |
| Disease | Cancer |
| Growth Properties | Embedded 3D Culture |
| Biosafety Level | 1 |
| Growth conditions | 37℃, 95% Air, 5% CO2 |
| Size/Quantity | 1 |
| Product format | Frozen |
| Shipping Info | Dry Ice |
| Storage conditions | Liquid Nitrogen |
View Product Image
Human Cervical Cancer Organoid is a 3D patient-derived tumor model cultured from resected cervical carcinoma tissue. Developed using cancer stem-like cells, it faithfully preserves the histopathological structure, molecular alterations, and HPV-related genetic signatures of the original tumor. The organoid exhibits long-term viability, allowing for continuous expansion while maintaining the intratumoral heterogeneity and architecture seen in vivo. It provides a highly reliable and physiologically relevant platform for studying cervical cancer progression and therapeutic response in a controlled setting.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Human Cervical Cancer Organoid supports a broad range of applications, including antiviral therapy evaluation, anti-cancer drug screening, radiotherapy resistance research, and biomarker discovery for early diagnosis. It is particularly valuable in studying HPV-driven oncogenesis and testing immunotherapy strategies, such as immune checkpoint inhibitors or tumor-infiltrating lymphocyte co-cultures. Its personalized nature allows for precision medicine approaches, guiding individualized treatment decisions based on tumor-specific behavior.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
